pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,614 catalysts · 6,271 phase readout · 2,337 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,271
  • 8k filing2,337
  • earnings390
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07569107: Learning Curve Analysis of Double-Lumen Tube Placement in Anesthesiology Residents: The Impact of Prior Experience and Laryngoscope Type

Sponsor: Ankara Ataturk Sanatorium Training and Research Hospital. Phase: . Conditions: Learning Curves and Outcomes of Simulation-based Training, Double Lumen Tube Intubation, Anesthesiology Residency Training, Experience, Laryngoscopes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07667192: Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer

Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy. Phase: . Conditions: Recurrent Gynecologic Cancer, Recurrent Uterine Cancer, Recurrent Cervical Cancer, Recurrent Vaginal Cancer, Recurrent Vulvar Cancer, Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Primary Peritoneal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07762911: Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07599436: Laughter Yoga and Sleep Hygiene Training for College Students With Premenstrual Syndrome

Sponsor: Gazi University. Phase: NA. Conditions: Laughter Yoga, Premenstrual Syndrome-PMS, Stress, Sleep Quality

full page →ctgov ↗
›RECRUITINGphase readoutNCT07565311: Two-week Intensive Outpatient Trauma Treatment.

Sponsor: Oslo University Hospital. Phase: NA. Conditions: Posttraumatic Stress Disorder (PTSD)

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07130500: Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

Sponsor: Stanford University. Phase: NA. Conditions: Schizophrenia Disorder, Schizoaffective Disorder, Bipolar Disorder (BD), Substance Use Disorder (SUD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07698392: Dynamic Neuromuscular Stabilization Versus Corrective Exercises in Upper Cross Syndrome

Sponsor: Cairo University. Phase: NA. Conditions: Upper Crossed Syndrome, Upper Cross Syndrome, Upper Crossed Syndorme

full page →ctgov ↗
›RECRUITINGphase readoutNCT04544592: UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Sponsor: University of Colorado, Denver. Phase: PHASE1. Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07598136: A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers

Sponsor: RAI Services Company. Phase: NA. Conditions: Smoking, Tobacco

full page →ctgov ↗
›RECRUITINGphase readoutNCT06246136: Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery

Sponsor: Elios Vision, Inc.. Phase: NA. Conditions: Open Angle Glaucoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07435636: Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis

Sponsor: Clinical Hub for Interventional Research (CHOIR). Phase: PHASE2. Conditions: Clonal Cytopenia of Uncertain Significance, CCUS Clonal Cytopenia of Undetermined Significance, Clonal Hematopoiesis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07088536: Occupational Situation and Return to Work of Urological Patients

Sponsor: Jagiellonian University. Phase: . Conditions: Bladder Cancer, Prostate Cancer, Renal Cancer, Urinary Stones

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07756736: Psilocybin Therapy for Methamphetamine Use Disorder and HIV

Sponsor: Nicky Mehtani, MD, MPH. Phase: PHASE2. Conditions: Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV)

full page →ctgov ↗
›COMPLETEDphase readoutNCT00748111: Thrombus and Inflammation Study in Sudden Cardiac DEath

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Sudden Cardiac Death, Acute Myocardial Infarction

full page →ctgov ↗
›RECRUITINGphase readoutNCT06096207: DBS for Depression

Sponsor: Northwell Health. Phase: PHASE1. Conditions: Treatment Resistant Depression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07703592: Comparison of Manual PAOP and Automatic PAOP (Smart Wedge)

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Septic Shock

full page →ctgov ↗
›COMPLETEDphase readoutNCT07561736: Comparison of Surgical Blade No. 11 and Ophthalmic Knife in Idiopathic Clubfoot Patients

Sponsor: Muhammad Aamir Latif. Phase: . Conditions: Clubfoot

full page →ctgov ↗
›COMPLETEDphase readoutNCT05947799: A Comparative Study on the Effectiveness of Video vs Text-Based Education in Heart Failure

Sponsor: Stanford University. Phase: NA. Conditions: Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07321899: Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Sponsor: Medtronic Cardiovascular. Phase: NA. Conditions: Severe Tricuspid Regurgitation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07418398: Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength.

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Spinal Cord Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT06370832: Inspiratory Muscle Training in Lung Transplant Candidates

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Inspiratory Muscle Training

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07071532: A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder

Sponsor: AbbVie. Phase: PHASE1. Conditions: Bipolar Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06517563: Effects of VMX-C001 on the Anticoagulant Effect of Different Forms of Heparin

Sponsor: VarmX B.V.. Phase: PHASE1. Conditions: Coagulation Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT05171387: Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer

Sponsor: Bayer. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06133387: PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

Sponsor: EndoQuest Robotics, Inc.. Phase: NA. Conditions: Colorectal Lesion, Colorectal Adenoma, Colorectal Polyp, Rectal Lesion, Rectal Adenoma, Rectal Polyp, Sigmoid; Lesion, Sigmoid Colon Polyp

full page →ctgov ↗
›RECRUITINGphase readoutNCT06188793: Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients

Sponsor: University of Michigan. Phase: NA. Conditions: Inflammatory Bowel Diseases

full page →ctgov ↗
›COMPLETEDphase readoutNCT05654493: Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

Sponsor: Mayo Clinic. Phase: . Conditions: Glaucoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT01282021: Molecular Immunohematology in Ethiopian Sub-Populations

Sponsor: National Institutes of Health Clinical Center (CC). Phase: . Conditions: Immunohematology

full page →ctgov ↗
›COMPLETEDphase readoutNCT07547514: The Effects of Yoga on Sensory, Motor, Cognitive Skills, and Perceived Stress in Children With Developmental Coordination Disorder

Sponsor: Fenerbahce University. Phase: NA. Conditions: Development Coordination Disorder, Motor Coordination or Function; Developmental Disorder, Sensory Integration Disorder, Perceived Stres Level, Cognitive Ability General

full page →ctgov ↗
›COMPLETEDphase readoutNCT05083416: Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome

Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: Head and Neck Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07127016: Mindfulness in Nonflaccid Facial Paralysis

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Facial Paralysis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07652216: Bone Defects Reconstruction After Dentigerous Cyst Enucleation With Autogenous Demineralized Dentin Matrix- ADDM and Advanced Platelet-Rich Fibrin- A-PRF.

Sponsor: Jagiellonian University. Phase: NA. Conditions: Impact Molar, Mandible Cyst, Bone Regeneration, Platelet Rich Fibrin, Dentigerous Cyst, Dentin Matrix, Autogenous Dentin Graft, Demineralized Dentin Matrix, Impacted Lower Third Molar, Impacted Mandibular Third Molar

full page →ctgov ↗
›RECRUITINGphase readoutNCT06960616: Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy

Sponsor: Massachusetts Eye and Ear Infirmary. Phase: NA. Conditions: Deafness, Cochlear Hearing Loss

full page →ctgov ↗
›COMPLETEDphase readoutNCT05492006: Immune Response and Affective States of Elderly and 50+ Individuals After Intentional and Indirect Contact With Nature

Sponsor: Hospital Israelita Albert Einstein. Phase: NA. Conditions: Elderly

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07273006: Percutaneous Electrical Nerve Stimulation As Alternative To Nerve Blocks In Anesthesia, Pain Medicine And Rehabilitation Of Nonspecific Chronic Pain

Sponsor: Universidad Complutense de Madrid. Phase: PHASE4. Conditions: Non-specific Low Back Pain (NSLBP), Facet Joint Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05736406: A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma

Sponsor: Hemerion Therapeutics. Phase: PHASE1. Conditions: Primary Glioblastoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07592806: CRISTEL Study: Monitoring of Pregnancies in Women After Solid Organ Transplantation

Sponsor: Hopital Foch. Phase: NA. Conditions: Surgical Operation With Transplant of Whole Organ

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07757204: An Open-label Long-term Safety Study of Buntanetap in Participants With AD

Sponsor: Annovis Bio Inc.. Phase: PHASE2. Conditions: Alzheimer's Dementia (AD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06611384: Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Sponsor: Rohan Dharmakumar. Phase: . Conditions: Acute Myocardial Infarction

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05700084: Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT05427084: Canagliflozin Targeting Vascular Inflammation

Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE2. Conditions: Diabetes Type 2, Coronary Artery Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05272384: Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Hodgkin Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07374484: Longitudinal Dynamics of AT1R Antibodies in Kidney Transplant Recipients

Sponsor: Seoul National University Hospital. Phase: . Conditions: Kidney Transplantation, Graft Survival, Angiotensin II Type 1 Receptor Antibody

full page →ctgov ↗
›COMPLETEDphase readoutNCT04766684: Clubfoot Tenotomy Trial

Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Clubfoot

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07631884: Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Sponsor: Haihua Yuan. Phase: PHASE2. Conditions: Solid Tumors, Neoplasms (Cancer / Tumors), Advanced Malignant Solid Neoplasm, Locally Advanced Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, HER2 Expression, Biliary Tract Neoplasms, Endometrial Neoplasms, Urothelial Carcinoma (UC), Pancreatic Neoplasms, Colorectal Neoplasms, Gastric Neoplasms, Non-Small Cell Lung Carcinoma (NSCLC), Head and Neck Neoplasms, Cervical Neoplasms

full page →ctgov ↗
›RECRUITINGphase readoutNCT07087184: Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Heart Diseases, Cardiovascular Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05416333: Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

Sponsor: Wake Forest University Health Sciences. Phase: EARLY_PHASE1. Conditions: Central Centrifugal Cicatricial Alopecia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06865638: Efficacy and Safety of Colorectal Anastomotic Leak Testing

Sponsor: Nanchong Central Hospital. Phase: NA. Conditions: Colorectal Cancer, Leakage Testing, Colorectal Surgery, Complications, Anastomotic Leakage

full page →ctgov ↗
›RECRUITINGphase readoutNCT06835738: Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Nutrient Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07284758: A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Sponsor: C4 Therapeutics, Inc.. Phase: PHASE2. Conditions: Multiple Myeloma, Relapsed/Refractory Multiple Myeloma

full page →ctgov ↗
← prev
page 172 of 173
next →